← Open Payments lookup

GLORIA VERTIN: Open Payments

NPI 1851901623 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$249 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $249

Food & beverage: $249
CompanyPaymentsAmount
Novo Nordisk Inc3$50
Lilly USA, LLC3$47
Amgen Inc.2$32
Axsome Therapeutics, Inc.1$30
GlaxoSmithKline, LLC.2$28
AstraZeneca Pharmaceuticals LP1$18
ABBVIE INC.1$16
Astellas Pharma US Inc1$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: MOUNJARO, Ozempic, Auvelity, SHINGRIX, BREZTRI, REPATHA, Wegovy, UBRELVY.

Industry payments across TX — which companies pay providers there.